偉思醫療(688580.SH):擬對“康復設備組裝調試項目”進行變更和延期
格隆匯6月21日丨偉思醫療(688580.SH)公佈,公司原計劃擬對“康復設備組裝調試項目”進行終止實施,但經過公司再次討論後,為了充分發揮募集資金的作用,認為“偉思醫療總部研發經濟園”項目能夠涵蓋“康復設備組裝調試項目”的建設內容,項目具有延續性,對“康復設備組裝調試項目”進行變更和延期更有利於提高募集資金的使用效率,因此經過公司內部討論並再次履行決策程序,擬對“康復設備組裝調試項目”進行變更和延期。
公司新建設的“偉思醫療總部研發經濟園”項目,通過購地方式新建,用地面積近2.4萬平方米,總建築面積近7萬平方米,計劃總投資約5億元,集合研發、生產、辦公等多種用途,其中與研發相關的辦公面積約10000平方米,投資金額約1.25億元;與生產及相關辦公的面積約9000平方米,投資金額約1.37億元。該項目已於2022年4月開始動工建設,預計2024年末正式投入使用。
“偉思醫療總部研發經濟園”項目的建設內容,涵蓋了“康復設備組裝調試項目”的建設內容,由於“偉思醫療總部研發經濟園”建設週期較長,“康復設備組裝調試項目”預定可使用狀態日期由2022年7月延期至2024年12月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.